| Device Classification Name |
Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
|
| 510(k) Number |
K251289 |
| Device Name |
WELLlife COVID-19 Antigen Test Rx |
| Applicant |
| Guangzhou Wondfo Biotech Co., Ltd. |
| #8 Lizhishan Rd., Science City, Huangpu District |
|
Guangzhou,
CN
510663
|
|
| Applicant Contact |
Kaiyu Xiao |
| Correspondent |
| Guangzhou Wondfo Biotech Co., Ltd. |
| #8 Lizhishan Rd., Science City, Huangpu District |
|
Guangzhou,
CN
510663
|
|
| Correspondent Contact |
Kaiyu Xiao |
| Classification Product Code |
|
| Date Received | 04/25/2025 |
| Decision Date | 10/22/2025 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Microbiology
|
| 510k Review Panel |
Microbiology
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Dual Track
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|